Peter Hurt

Peter joined InflaRx in 2019 with 15 years experience in healthcare industry and started his career in clinical development at a global medical devices company (Biotronik) in cardiovascular research. Following roles included clinical project management at Bristol-Myers Squibb, a leading pharmaceutical company and positions in clinical research and drug safety management in various therapeutic areas, including oncology and auto-immune diseases. Peter has gained experience in drug safety management including set-up of safety monitoring structures for several biotech companies for more than ten years. He graduated from the Technical University of Berlin (TUB) as an engineer for biotechnology and holds a Ph.D. from TUB based on immunogenomic research at the Max Planck Institute for Molecular Genetics (Berlin).